Content Details
Information on this page was last modified on : 2024/06/21 4:59:59 PM

opdualag (nivolumab and relatlimab) injection

Belongs to Category

How It Works

Nivolumab is a PD-1 (programmed death-1) inhibitor, while relatlimab is a LAG-3 (lymphocyte-activation gene 3) inhibitor. Both drugs work by blocking the pathways that cancer cells use to evade the immune system. Nivolumab inhibits the PD-1 pathway, which allows T cells to recognize and attack cancer cells. Relatlimab inhibits the LAG-3 pathway, which further enhances the T cell response against tumors. Together, these drugs provide a synergistic effect, boosting the immune system’s ability to target and destroy cancer cells.

Side Effects

  • Fatigue
  • Diarrhea
  • Rash
  • Pruritus (itching)
  • Nausea
  • Decreased appetite
  • Musculoskeletal pain
  • Infusion-related reactions
  • Elevated liver enzymes
  • Hypothyroidism
  • Pneumonitis
  • Colitis


  • Advanced or metastatic melanoma
  • Other cancers as determined by ongoing clinical trials and approvals


  • Severe hypersensitivity to nivolumab, relatlimab, or any of the excipients in the formulation
  • Pregnancy and breastfeeding (due to potential harm to the fetus or infant)

Price Comparison in Different Countries

Country Price (per injection) Reference
Pakistan Approximately PKR 800,000 Pakistan
United States USD 10,000 GoodRx
United Kingdom GBP 7,500 NHS UK
Canada CAD 12,000 Health Canada
Australia AUD 15,000 PBS Australia

Top 5 Global Pharmaceutical Brands

  1. Pfizer
  2. Novartis
  3. Roche
  4. Sanofi
  5. GlaxoSmithKline (GSK)


Opdualag (nivolumab and relatlimab) is a novel combination immunotherapy that leverages the power of the immune system to combat advanced cancers, particularly melanoma. By inhibiting both the PD-1 and LAG-3 pathways, this drug enhances T cell activity against cancer cells. Patients should be aware of potential side effects and contraindications, and should work closely with their healthcare providers to determine the best course of treatment. The cost of Opdualag can vary significantly between countries, reflecting differences in healthcare systems and pricing structures. Exploring financial assistance options may help manage the cost of treatment.


Additional Information:

One of the following licensed pharmacy from the nearest location will deliver opdualag (nivolumab and relatlimab) injection. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions


There are no reviews yet.

Be the first to review “opdualag (nivolumab and relatlimab) injection”
Shopping Cart